Xenotropic MLV envelope proteins induce tumor cells to secrete factors that promote the formation of immature blood vessels

Retrovirology

Volumn 10, Issue 1, 2013, Pages

  Murgai, Meera ^a   Thomas, James ^b   Cherepanova, Olga ^a   Delviks Frankenberry, Krista ^d   Deeble, Paul ^c   Pathak, Vinay K ^d   Rekosh, David ^a   Owens, Gary ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MARY BALDWIN COLLEGE   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSGELIN; VIRUS ENVELOPE PROTEIN;

ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; DOWN REGULATION; ENVELOPE GENE; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC MARKER; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; METASTASIS POTENTIAL; MOUSE; MURINE LEUKEMIA VIRUS; MYH11 GENE; NONHUMAN; PERICYTE; PROSTATE CANCER; PROTEIN FUNCTION; PSEUDOTYPING; REOVIRUS INFECTION; SMOOTH MUSCLE FIBER; TAGLN GENE; TUMOR VASCULARIZATION; TUMOR VOLUME; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR SMOOTH MUSCLE; VIRION; XENOTROPIC VIRUS;

ANIMALS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; GENE PRODUCTS, ENV; HUMANS; MALE; MICE; MICE, INBRED BALB C; NEOVASCULARIZATION, PATHOLOGIC; PROSTATIC NEOPLASMS; XENOTROPIC MURINE LEUKEMIA VIRUS-RELATED VIRUS;

MURINAE; MUS MUSCULUS; XENOTROPIC MURINE LEUKEMIA VIRUS;

EID: 84875304000     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-10-34     Document Type: Article

References (36)

1. Metzger MJ, Holguin CJ, Mendoza R, Miller AD. The prostate cancer-associated human retrovirus XMRV lacks direct transforming activity but can induce low rates of transformation in cultured cells. J Virol 2010, 84:1874-1880. 10.1128/JVI.01941-09, 2812358, 20007266.
2. Lombardi VC, Ruscetti FW, Gupta Das J, Pfost MA, Hagen KS, Peterson DL, Ruscetti SK, Bagni RK, Petrow-Sadowski C, Gold B, Dean M, Silverman RH, Mikovits JA. Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 2009, 326:585-589. 10.1126/science.1179052, 19815723.
3. Silverman RH. A scientific journey through the 2-5A/RNase L system. Cytokine Growth Factor Rev 2007, 18:381-388. 10.1016/j.cytogfr.2007.06.012, 2075094, 17681844.
4. Pandhare-Dash J, Mantri CK, Gong Y, Chen Z, Dash C. XMRV accelerates cellular proliferation, transformational activity, and invasiveness of prostate cancer cells by downregulating p27Kip1. Prostate 2011, 72:886-897. 3275676, 21932423.
5. Stieler K, Schumacher U, Horst AK, Fischer N. XMRV induces cell migration, cytokine expression and tumor angiogenesis: are 22rv1 cells a suitable prostate cancer model?. PLoS One 2012, 7:e42321. 10.1371/journal.pone.0042321, 3407105, 22848758.
6. Hohn O, Krause H, Barbarotto P, Niederstadt L, Beimforde N, Denner J, Miller K, Kurth R, Bannert N. Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patients. Retrovirology 2009, 6:92. 10.1186/1742-4690-6-92, 2770519, 19835577.
7. Knox K, Carrigan D, Simmons G, Teque F, Zhou Y, Hackett J, Qiu X, Luk KC, Schochetman G, Knox A, Kogelnik AM, Levy JA. No evidence of murine-like gammaretroviruses in CFS patients previously identified as XMRV-infected. Science 2011, 333:94-97. 10.1126/science.1204963, 21628393.
8. van Kuppeveld FJM, Jong ASD, Lanke KH, Verhaegh GW, Melchers WJG, Swanink CMA, Bleijenberg G, Netea MG, Galama JMD, van der Meer JWM. Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: retrospective analysis of samples from an established cohort. BMJ 2010, 340:c1018-c1018. 10.1136/bmj.c1018, 2829122, 20185493.
9. Switzer WM, Jia H, Zheng H, Tang S, Heneine W. No Association of Xenotropic Murine Leukemia Virus-Related Viruses with Prostate Cancer. PLoS One 2011, 6:e19065. 10.1371/journal.pone.0019065, 3087753, 21573232.
10. Paprotka T, Delviks-Frankenberry KA, Cingoz O, Martinez A, Kung HJ, Tepper CG, Hu WS, Fivash MJ, Coffin JM, Pathak VK. Recombinant Origin of the Retrovirus XMRV. Science 2011, 333:97-101. 10.1126/science.1205292, 3278917, 21628392.
11. Thalmann GN, Sikes RA, Wu TT, Degeorges A, Chang SM, Ozen M, Pathak S, Chung LW. LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis. Prostate 2000, 44:91-103. Jul 1-44(2), 10.1002/1097-0045(20000701)44:2<91::AID-PROS1>3.0.CO;2-L, 10881018.
12. Oakes B, Tai AK, Cingöz O, Henefield MH, Levine S, Coffin JM, Huber BT. Contamination of human DNA samples with mouse DNA can lead to false detection of XMRV-like sequences. Retrovirology 2010, 7:109. 10.1186/1742-4690-7-109, 3022687, 21171973.
13. Gupta Das J, Luk K-C, Tang N, Gaughan C, Klein EA, Kandel ES, Hackett J, Silverman RH. Absence of XMRV and Closely Related Viruses in Primary Prostate Cancer Tissues Used to Derive the XMRV-Infected Cell Line 22Rv1. PLoS One 2012, 7:e36072. 10.1371/journal.pone.0036072, 3353988, 22615748.
14. Peredo C, O'Reilly L, Gray K, Roth MJ. Characterization of chimeras between the ecotropic Moloney murine leukemia virus and the amphotropic 4070A envelope proteins. J Virol 1996, 70:3142-3152. 190177, 8627794.
15. Fishman JA, Scobie L, Takeuchi Y. Xenotransplantation-associated infectious risk: a WHO consultation. Xenotransplantation 2012, 19:72-81. 10.1111/j.1399-3089.2012.00693.x, 22497509.
16. Hanahan D, Weinberg RA. Hallmarks of Cancer: The Next Generation. Cell 2011, 144:646-674. 10.1016/j.cell.2011.02.013, 21376230.
17. Levy JA, Pincus T. Demonstration of biological activity of a murine leukemia virus of New Zealand black mice. Science 1970, 170:326-327. 10.1126/science.170.3955.326, 4318971.
18. Xian X. Pericytes limit tumor cell metastasis. J Clin Invest 2006, 116:642-651. 10.1172/JCI25705, 1361347, 16470244.
19. Kim S, Kim N, Dong B, Boren D, Lee SA, Gupta Das J, Gaughan C, Klein EA, Lee C, Silverman RH, Chow SA. Integration Site Preference of Xenotropic Murine Leukemia Virus-Related Virus, a New Human Retrovirus Associated with Prostate Cancer. J Virol 2008, 82:9964-9977. 10.1128/JVI.01299-08, 2566297, 18684813.
20. Ramaswamy S, Ross KN, Lander ES, Golub TR. A molecular signature of metastasis in primary solid tumors. Nat Genet 2002, 33:49-54.
21. Goel S, Wong AH-K, Jain RK. Vascular normalization as a therapeutic strategy for malignant and nonmalignant disease. Cold Spring Harb Perspect Med 2012, 2:a006486. 10.1101/cshperspect.a006486, 3282493, 22393532.
22. de Groot JF, Fuller G, Kumar AJ, Piao Y, Eterovic K, Ji Y, Conrad CA. Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice. Neuro Oncol 2010, 12:233-242. 10.1093/neuonc/nop027, 2940588, 20167811.
23. Tong RT, Boucher Y, Kozin SV, Winkler F, Hicklin DJ, Jain RK. Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors. Cancer Res 2004, 64:3731-3736. 10.1158/0008-5472.CAN-04-0074, 15172975.
24. Vaughan AE, Mendoza R, Aranda R, Battini JL, Miller AD. Xpr1 Is an Atypical G-Protein-Coupled Receptor That Mediates Xenotropic and Polytropic Murine Retrovirus Neurotoxicity. J Virol 2012, 86:1661-1669. 10.1128/JVI.06073-11, 3264382, 22090134.
25. Yan Y, Liu Q, Kozak CA. Six host range variants of the xenotropic/polytropic gammaretroviruses define determinants for entry in the XPR1 cell surface receptor. Retrovirology 2009, 6:87. 10.1186/1742-4690-6-87, 2768677, 19811656.
26. Setty MKHG, Devadas K, Ragupathy V, Ravichandran V, Tang S, Wood O, Gaddam DS, Lee S, Hewlett IK. XMRV: usage of receptors and potential co-receptors. Virol J 2011, 8:423. 10.1186/1743-422X-8-423, 3184104, 21896167.
27. Stieler K, Fischer N. Apobec 3G efficiently reduces infectivity of the human exogenous gammaretrovirus XMRV. PLoS One 2010, 5:e11738. 10.1371/journal.pone.0011738, 2909211, 20668529.
28. Rennert H, Bercovich D, Hubert A, Abeliovich D, Rozovsky U, Bar-Shira A, Soloviov S, Schreiber L, Matzkin H, Orr-Urtreger A. A Novel Founder Mutation in the RNASEL gene, 471delAAAG, is associated with prostate cancer in Ashkenazi Jews. Am J Hum Genet 2002, 71(4):981-984. 10.1086/342775, 378554, 12145743.
29. Hofacre A, Fan H. Jaagsiekte Sheep Retrovirus Biology and Oncogenesis. Viruses 2010, 2:2618-2648. 10.3390/v2122618, 3185594, 21994634.
30. Maeda N, Fan H, Yoshikai Y. Oncogenesis by retroviruses: old and new paradigms. Rev Med Virol 2008, 18:387-405. 10.1002/rmv.592, 18729235.
31. Stieler K, Schulz C, Lavanya M, Aepfelbacher M, Stocking C, Fischer N. Host range and cellular tropism of the human exogenous gammaretrovirus XMRV. Virology 2010, 399:23-30. 10.1016/j.virol.2009.12.028, 20110097.
32. Groom HCT, Bishop KN. The tale of xenotropic murine leukemia virus-related virus. J Gen Virol 2012, 93:915-924. 10.1099/vir.0.041038-0, 22357751.
33. ImageJ http://imagej.nih.gov.
34. Bolte S, Cordelières FP. A guided tour into subcellular colocalization analysis in light microscopy. J Microsc 2006, 224:213-232. 10.1111/j.1365-2818.2006.01706.x, 17210054.
35. Geisterfer AA, Peach MJ, Owens GK. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res 1988, 62:749-756. 10.1161/01.RES.62.4.749, 3280155.
36. Urisman A, Molinaro RJ, Fischer N, Plummer SJ, Casey G, Klein EA, Malathi K, Magi-Galluzzi C, Tubbs RR, Ganem D, Silverman RH, DeRisi JL. Identification of a Novel Gammaretrovirus in Prostate Tumors of Patients Homozygous for R462Q RNASEL Variant. PLoS Pathog 2006, 2:e25. 10.1371/journal.ppat.0020025, 1434790, 16609730.